MENU
BIAF
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

bioAffinity Technologies (BIAF) Ownership - Who owns bioAffinity Technologies?

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more

Profile

Industry
N/A
Address
22211 W Interstate 10
Phone
+1 210 698-5334
Employees
75
Web
https://www.bioaffinitytech.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
9.67M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
670K
Revenue
7.68M
Risk (Beta)
2.39
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
13.66 USD as % of share price

Fundamentals

BIAF
Capitalization
9.67M
P/E Ratio
N/A
Risk (Beta)
2.39
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
670K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
13.66%
Revenue
7.68M
ROE
N/A
Book Value
-2.14M
P/B Ratio
4.61
Cash Flow
N/A
Earnings
-17.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
197K
Current Ratio
0.64
Current Revenue Per Employee
22271.63
Dividends Per Share - Security
N/A
EBITDA
-11M
Float
N/A
Float - Current
N/A
Gross Income Margin
19.92
Revenue To Assets
-204.93
Shares Held By Institutions
165K
Shares Outstanding - Current
4.5M
Total Liabilities
6.89M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-92.125
View a ticker or compare two or three
BIAF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
22211 W Interstate 10
Phone
+1 210 698-5334
Employees
75
Web
https://www.bioaffinitytech.com